Positron Emission Tomography (PET) Study With [11C]Raclopride to Determine Central D2 Dopamine Occupancy of SEROQUEL

NCT00832221 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression

Interventions

DRUG: SEROQUEL XR (quetiapine)
DRUG: SEROQUEL IR (quetiapine)
DRUG: radioligand [11C]raclopride

Sponsor

AstraZeneca